Last updated 2026-07-20
Total raised
—
Last: Undisclosed Round 2024-02
Stage
Series A
Founded
2019
Headcount
6
HQ
Haifa, Israel
Sector
Health Tech & Life Sciences
About
Canopy Immuno-Therapeutics is a pre-clinical stage biotech company developing a novel immunotherapeutic approach for dozens of immune-related disorders. The company focuses on developing and commercializing biopharmaceuticals based on a novel immunotherapeutic approach for autoimmunity. Their proprietary Reverse-Immunization platform aims to eliminate antigen-specific immunity, providing non-immunosuppressive and potentially curative treatments. Canopy's solution involves Antigen-drug conjugates (AgDCs) that selectively clear pathological antibodies and autoreactive B-cells while preserving protective immunity. The company's vision is to develop best-in-class, non-immunosuppressive, and potentially curative therapies for antibody-mediated autoimmune conditions.
Offices
Haifa, Israel · HQ / main office
Q&A
- What is Canopy Immuno-Therapeutics' primary focus?
- Canopy Immuno-Therapeutics is a pre-clinical stage biotech company focused on developing a new class of biologics for the elimination of antigen-specific immunity, aiming to provide non-immunosuppressive treatments for autoimmune, allergic, and other antibody-mediated conditions using its proprietary Reverse-Immunization platform.
- When was Canopy Immuno-Therapeutics founded?
- Canopy Immuno-Therapeutics was founded in December 2019.
- What is the current employee count for Canopy Immuno-Therapeutics?
- Canopy Immuno-Therapeutics has 6 employees, falling within the 1-10 employee bucket.
- Which investors participated in Canopy Immuno-Therapeutics' funding round in February 2024?
- TLV Partners participated in Canopy Immuno-Therapeutics' funding round in February 2024.
- What is Canopy Immuno-Therapeutics' current funding stage?
- Canopy Immuno-Therapeutics is currently in its Series A funding stage.
- What sector does Canopy Immuno-Therapeutics primarily operate in?
- Canopy Immuno-Therapeutics' primary sector is Health Tech & Life Sciences, specifically within Pharma & Medical Biotechnology and Drugs Discovery & Development.
- What is the product stage of Canopy Immuno-Therapeutics?
- Canopy Immuno-Therapeutics' product is currently in the R&D stage.
- What technologies does Canopy Immuno-Therapeutics utilize?
- Canopy Immuno-Therapeutics utilizes Platforms & Interfaces, Software, and Artificial Intelligence technologies.
Team · 10
Dr. Kfir Oved
Founder · Founder, CEO & Board Member
Dr. Cedric Francois
Chairman
John Cox
Board Member
Dr. Westley Nolin
Board Member
Shahar Tzafrir
Board Member
Dr. Galit Denkberg
Vice President, Discovery
Dr. Sharon Reef
Vice President, CMC
Dr. Inbar Arman
Director of Immunology
Sharon Oz
IP Manager
Dr. Roei Mazor
Vice President, Clinical Development & Medical Affairs
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Platforms & InterfacesSoftwareArtificial Intelligence
Target customers
Healthcare & Life SciencesLife SciencesBiotechnology
Business model
B2B
Highlights
Verified
Tags
biotechnologyinflammatory-diseasesallergytreatmentsartificial-intelligencesoftware-platformlife-sciencesimmunologyimmuno-theraphydrug-developmentimmunotherapy
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | canopy-biotech.com |
|---|---|
| linkedin.com/in/kfir-oved-96b2201b |
Identifiers & details
| Founded | 2019-12 |
|---|---|
| Employees (exact) | 6 |
Radar intelligence
Patents
| EPO | 9 |
|---|
Web history (Wayback)
| Domain | canopy-biotech.com |
|---|
Certificate / subdomain footprint
| Subdomains | 1 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516091204 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2019-10-02 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 2 — shares_capital (2) |
| Registered address | הגלים 5 מגדים |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-17 | העברת מניות |
| 2025-11-02 | הקצאת מניות |